CS
RDUS

Candriam SCA’s Radius Health, Inc. RDUS Stock Holding History

Candriam SCA’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-403,068
Closed -$5M – 887
2021
Q3 		$5M Hold
403,068
– – 0.03% 401
2021
Q2 		$7.35M Buy
403,068
+50,501
+14% +$1M 0.05% 331
2021
Q1 		$6.05M Hold
352,567
– – 0.05% 340
2020
Q4 		$6.3M Buy
352,567
+40,542
+13% +$609K 0.05% 349
2020
Q3 		$3.54M Hold
312,025
– – 0.03% 407
2020
Q2 		$4.25M Buy
312,025
+50,000
+19% +$689K 0.04% 367
2020
Q1 		$5.16M Hold
262,025
– – 0.06% 336
2019
Q4 		$5.28M Sell
262,025
-42,000
-14% -$1.02M 0.06% 343
2019
Q3 		$7.83M Hold
304,025
– – 0.1% 233
2019
Q2 		$7.37M Hold
304,025
– – 0.09% 245
2019
Q1 		$6.06M Hold
304,025
– – 0.08% 281
2018
Q4 		$5.01M Hold
304,025
– – 0.08% 283
2018
Q3 		$5.41M Buy
304,025
+23,500
+8% +$532K 0.07% 299
2018
Q2 		$8.27M Buy
280,525
+63,000
+29% +$1.99M 0.13% 198
2018
Q1 		$7.82M Buy
217,525
+22,525
+12% +$814K 0.13% 197
2017
Q4 		$6.2M Buy
195,000
+53,000
+37% +$1.66M 0.11% 229
2017
Q3 		$5.47M Buy
142,000
+27,000
+23% +$1.06M 0.1% 246
2017
Q2 		$5.2M Buy
115,000
+56,000
+95% +$2.14M 0.1% 247
2017
Q1 		$2.28M Sell
59,000
-3,000
-5% -$126K 0.04% 418
2016
Q4 		$2.36M Buy
62,000
+8,000
+15% +$381K 0.05% 339
2016
Q3 		$2.92M Sell
54,000
-61,000
-53% -$3.1M 0.07% 285
2016
Q2 		$4.23M Buy
115,000
+51,000
+80% +$1.8M 0.11% 207
2016
Q1 		$2M Sell
64,000
-26,000
-29% -$899K 0.05% 321
2015
Q4 		$5.54M Sell
90,000
-14,400
-14% -$909K 0.15% 157
2015
Q3 		$7.24M Sell
104,400
-25,600
-20% -$1.78M 0.18% 151
2015
Q2 		$8.8M Sell
130,000
-16,000
-11% -$745K 0.18% 158
2015
Q1 		$6.01M Buy
146,000
+81,000
+125% +$3.64M 0.12% 226
2014
Q4 		$2.53M Buy
+65,000
New +$1.54M 0.05% 328

Other funds holding RDUS

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Candriam SCA's RDUS Position: Q4 2021 in Review

Candriam SCA sold out of Radius Health, Inc. (RDUS) in Q4 2021, closing a stake of 403,068 shares — an estimated $5M sold.

Candriam SCA first reported a position in RDUS in Q4 2014 and held it in 28 quarters. The position peaked at $8.8M in Q2 2015. 135 funds tracked by Wall St. Rank hold RDUS as of Q4 2021.

  • Candriam SCA reported no remaining Radius Health, Inc. position as of Q4 2021 after selling out during the quarter.
  • Candriam SCA sold 403,068 Radius Health, Inc. shares in Q4 2021, an estimated $5M.
  • Candriam SCA first reported a position in Radius Health, Inc. in Q4 2014 and held it in 28 quarters.
  • Candriam SCA's Radius Health, Inc. position peaked at $8.8M in Q2 2015.
  • 135 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2021.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.